↓ Skip to main content

American Association for Cancer Research

A DNA-Launched Nanoparticle Vaccine Elicits CD8+ T-cell Immunity to Promote In Vivo Tumor Control

Overview of attention for article published in Cancer Immunology Research, November 2020
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news
8 news outlets
twitter
6 X users
facebook
1 Facebook page

Citations

dimensions_citation
21 Dimensions

Readers on

mendeley
22 Mendeley
Title
A DNA-Launched Nanoparticle Vaccine Elicits CD8+ T-cell Immunity to Promote In Vivo Tumor Control
Published in
Cancer Immunology Research, November 2020
DOI 10.1158/2326-6066.cir-20-0061
Pubmed ID
Authors

Ziyang Xu, Neethu Chokkalingam, Edgar Tello-Ruiz, Megan C Wise, Mamadou A Bah, Susanne Walker, Nicholas J Tursi, Paul D Fisher, Katherine Schultheis, Kate E Broderick, Laurent Humeau, Daniel W Kulp, David B Weiner

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 22 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 4 18%
Student > Bachelor 3 14%
Student > Master 2 9%
Researcher 2 9%
Other 1 5%
Other 1 5%
Unknown 9 41%
Readers by discipline Count As %
Immunology and Microbiology 6 27%
Medicine and Dentistry 3 14%
Biochemistry, Genetics and Molecular Biology 2 9%
Agricultural and Biological Sciences 1 5%
Unknown 10 45%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 54. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 August 2021.
All research outputs
#804,634
of 25,753,031 outputs
Outputs from Cancer Immunology Research
#79
of 1,591 outputs
Outputs of similar age
#21,937
of 442,985 outputs
Outputs of similar age from Cancer Immunology Research
#2
of 34 outputs
Altmetric has tracked 25,753,031 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,591 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.1. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 442,985 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 34 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.